Annual long term liabilities:
$36.02M+$10.18M(+39.41%)Summary
- As of today (July 1, 2025), AKRO annual total long term liabilities is $36.02 million, with the most recent change of +$10.18 million (+39.41%) on December 31, 2024.
- During the last 3 years, AKRO annual long term liabilities has risen by +$34.71 million (+2647.52%).
- AKRO annual long term liabilities is now -71.12% below its all-time high of $124.73 million, reached on December 31, 2018.
Performance
AKRO Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$29.56M-$6.46M(-17.94%)Summary
- As of today (July 1, 2025), AKRO quarterly total long term liabilities is $29.56 million, with the most recent change of -$6.46 million (-17.94%) on March 31, 2025.
- Over the past year, AKRO quarterly long term liabilities has dropped by -$6.17 million (-17.28%).
- AKRO quarterly long term liabilities is now -76.30% below its all-time high of $124.73 million, reached on December 31, 2018.
Performance
AKRO quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AKRO Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +39.4% | -17.3% |
| 3 y3 years | +2647.5% | +2255.2% |
| 5 y5 years | +10000.0% | +10000.0% |
AKRO Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2647.5% | -17.9% | +178.7% |
| 5 y | 5-year | at high | >+9999.0% | -17.9% | >+9999.0% |
| alltime | all time | -71.1% | >+9999.0% | -76.3% | >+9999.0% |
AKRO Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $29.56M(-17.9%) |
| Dec 2024 | $36.02M(+39.4%) | $36.02M(+0.2%) |
| Sep 2024 | - | $35.93M(+0.4%) |
| Jun 2024 | - | $35.80M(+0.2%) |
| Mar 2024 | - | $35.73M(+38.3%) |
| Dec 2023 | $25.84M(+136.5%) | $25.84M(+8.8%) |
| Sep 2023 | - | $23.75M(-7.8%) |
| Jun 2023 | - | $25.77M(-0.1%) |
| Mar 2023 | - | $25.80M(+136.1%) |
| Dec 2022 | $10.93M(+733.3%) | $10.93M(+2.5%) |
| Sep 2022 | - | $10.66M(+0.5%) |
| Jun 2022 | - | $10.61M(+745.1%) |
| Mar 2022 | - | $1.25M(-4.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $1.31M(-13.5%) | $1.31M(-4.0%) |
| Sep 2021 | - | $1.36M(-3.7%) |
| Jun 2021 | - | $1.42M(-3.4%) |
| Mar 2021 | - | $1.47M(-3.2%) |
| Dec 2020 | $1.52M(+6491.3%) | $1.52M(-3.1%) |
| Sep 2020 | - | $1.56M(>+9900.0%) |
| Jun 2020 | - | $2000.00(-83.3%) |
| Mar 2020 | - | $12.00K(-47.8%) |
| Dec 2019 | $23.00K(-100.0%) | $23.00K(-32.4%) |
| Sep 2019 | - | $34.00K(-12.8%) |
| Jun 2019 | - | $39.00K(>+9900.0%) |
| Mar 2019 | - | $0.00(-100.0%) |
| Dec 2018 | $124.73M(+2394.6%) | $124.73M |
| Dec 2017 | $5.00M | - |
FAQ
- What is Akero Therapeutics annual total long term liabilities?
- What is the all time high annual long term liabilities for Akero Therapeutics?
- What is Akero Therapeutics annual long term liabilities year-on-year change?
- What is Akero Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Akero Therapeutics?
- What is Akero Therapeutics quarterly long term liabilities year-on-year change?
What is Akero Therapeutics annual total long term liabilities?
The current annual long term liabilities of AKRO is $36.02M
What is the all time high annual long term liabilities for Akero Therapeutics?
Akero Therapeutics all-time high annual total long term liabilities is $124.73M
What is Akero Therapeutics annual long term liabilities year-on-year change?
Over the past year, AKRO annual total long term liabilities has changed by +$10.18M (+39.41%)
What is Akero Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of AKRO is $29.56M
What is the all time high quarterly long term liabilities for Akero Therapeutics?
Akero Therapeutics all-time high quarterly total long term liabilities is $124.73M
What is Akero Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, AKRO quarterly total long term liabilities has changed by -$6.17M (-17.28%)